PCI患者-话题@MedSci

#PCI患者#

25篇内容 | 1256人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1786818, encodeId=ad051e8681879, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=Lancet：支持使用血小板功能或基因检测来优化PCI患者的药物选择, objectType=article, longId=210096, objectId=f8f921009607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8f921009607, replyNumber=0, likeNumber=61, createdTime=2021-05-16, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8f921009607, moduleTitle=Lancet：支持使用血小板功能或基因检测来优化PCI患者的药物选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8f921009607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786816, encodeId=a2ca1e8681656, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=ESC 2020热点解读之房颤PCI患者抗凝治疗进展, objectType=article, longId=201050, objectId=2db8201050df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2db8201050df, replyNumber=0, likeNumber=68, createdTime=2020-09-22, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2db8201050df, moduleTitle=ESC 2020热点解读之房颤PCI患者抗凝治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2db8201050df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786817, encodeId=62d11e86817f8, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=JAHA：肝脏纤维化评分作为预测择期PCI患者心血管预后的新工具, objectType=article, longId=206431, objectId=8bf7206431ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bf7206431ef, replyNumber=0, likeNumber=75, createdTime=2021-12-11, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bf7206431ef, moduleTitle=JAHA：肝脏纤维化评分作为预测择期PCI患者心血管预后的新工具, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bf7206431ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786815, encodeId=352b1e86815bd, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=JACC：单用替卡格雷对伴有糖尿病PCI患者的影响, objectType=article, longId=194338, objectId=337a19433873, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=337a19433873, replyNumber=0, likeNumber=105, createdTime=2020-10-26, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=337a19433873, moduleTitle=JACC：单用替卡格雷对伴有糖尿病PCI患者的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=337a19433873)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786814, encodeId=a6e51e868141c, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=NEJM：高出血风险PCI患者的选择——无聚合物药物涂层支架vs聚合物药物洗脱支架, objectType=article, longId=187964, objectId=dd1018e96451, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd1018e96451, replyNumber=0, likeNumber=86, createdTime=2020-10-31, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd1018e96451, moduleTitle=NEJM：高出血风险PCI患者的选择——无聚合物药物涂层支架vs聚合物药物洗脱支架, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd1018e96451)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786813, encodeId=d6a61e8681301, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=TCT 2019 | TWILIGHT研究重磅发布，高危PCI患者使用替格瑞洛单药治疗获益显著, objectType=article, longId=180192, objectId=981118019267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=981118019267, replyNumber=0, likeNumber=66, createdTime=2020-01-11, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=981118019267, moduleTitle=TCT 2019 | TWILIGHT研究重磅发布，高危PCI患者使用替格瑞洛单药治疗获益显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=981118019267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786812, encodeId=1f811e8681245, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=NEJM：原发性PCI患者口服P2Y12抑制剂的基因导向策略, objectType=article, longId=178970, objectId=02321e8970bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02321e8970bd, replyNumber=0, likeNumber=95, createdTime=2019-11-20, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02321e8970bd, moduleTitle=NEJM：原发性PCI患者口服P2Y12抑制剂的基因导向策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02321e8970bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786811, encodeId=ad5f1e8681188, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=Lancet：替格瑞洛对糖尿病伴稳定冠状动脉疾病并且既往PCI患者有益, objectType=article, longId=178657, objectId=dd551e86577d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd551e86577d, replyNumber=0, likeNumber=77, createdTime=2020-05-24, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd551e86577d, moduleTitle=Lancet：替格瑞洛对糖尿病伴稳定冠状动脉疾病并且既往PCI患者有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd551e86577d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786810, encodeId=6b491e8681027, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=JAMA：P2Y12抑制剂单药治疗对PCI患者心血管事件的影响研究, objectType=article, longId=173295, objectId=7d9e1e32952a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d9e1e32952a, replyNumber=0, likeNumber=58, createdTime=2020-03-29, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d9e1e32952a, moduleTitle=JAMA：P2Y12抑制剂单药治疗对PCI患者心血管事件的影响研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d9e1e32952a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786806, encodeId=15341e86806c2, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=Lancet：双抗血小板治疗缩短至6个月导致PCI患者心肌梗死风险增加, objectType=article, longId=132280, objectId=c43c13228055, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c43c13228055, replyNumber=0, likeNumber=80, createdTime=2018-10-21, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c43c13228055, moduleTitle=Lancet：双抗血小板治疗缩短至6个月导致PCI患者心肌梗死风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c43c13228055)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786809, encodeId=701f1e86809b3, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=Circulation：氯吡格雷低反应性PCI患者强化抗血小板治疗能获益更多？, objectType=article, longId=141962, objectId=112b14196221, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=112b14196221, replyNumber=0, likeNumber=70, createdTime=2019-05-17, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=112b14196221, moduleTitle=Circulation：氯吡格雷低反应性PCI患者强化抗血小板治疗能获益更多？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=112b14196221)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786807, encodeId=356a1e86807ad, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=美国大学发现他汀能减少PCI患者不良心脏事件的发生, objectType=article, longId=132300, objectId=13c013230001, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13c013230001, replyNumber=0, likeNumber=85, createdTime=2019-02-04, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13c013230001, moduleTitle=美国大学发现他汀能减少PCI患者不良心脏事件的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13c013230001)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786808, encodeId=75b21e86808ed, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=JAHA：我国≥75岁PCI患者负荷双联抗血小板治疗无临床获益且出血风险增加, objectType=article, longId=134286, objectId=4bf7134286bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bf7134286bd, replyNumber=0, likeNumber=55, createdTime=2018-04-29, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bf7134286bd, moduleTitle=JAHA：我国≥75岁PCI患者负荷双联抗血小板治疗无临床获益且出血风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bf7134286bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786805, encodeId=ca4e1e86805e4, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=Circ Cardiovasc Interv：他汀或可保护PCI患者手术中肾脏安全, objectType=article, longId=102943, objectId=ab2010294315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab2010294315, replyNumber=0, likeNumber=68, createdTime=2018-03-25, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab2010294315, moduleTitle=Circ Cardiovasc Interv：他汀或可保护PCI患者手术中肾脏安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab2010294315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786804, encodeId=88b61e86804d6, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=EHJ：中国择期PCI患者他汀强化未进一步获益(ISCAP研究), objectType=article, longId=61113, objectId=7a386111388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a386111388, replyNumber=0, likeNumber=69, createdTime=2016-06-10, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a386111388, moduleTitle=EHJ：中国择期PCI患者他汀强化未进一步获益(ISCAP研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a386111388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786803, encodeId=9b771e868030d, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=ESC 2015：PCI患者经桡动脉途径优于经股动脉（ISACS-TC注册研究）, objectType=article, longId=55894, objectId=1da955894c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1da955894c2, replyNumber=0, likeNumber=69, createdTime=2015-12-10, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1da955894c2, moduleTitle=ESC 2015：PCI患者经桡动脉途径优于经股动脉（ISACS-TC注册研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1da955894c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786802, encodeId=e2641e86802b7, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=JACC：双降脂策略治疗PCI患者疗效更优, objectType=article, longId=54112, objectId=a13a54112f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a13a54112f5, replyNumber=0, likeNumber=102, createdTime=2015-09-26, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a13a54112f5, moduleTitle=JACC：双降脂策略治疗PCI患者疗效更优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a13a54112f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786801, encodeId=21701e868011c, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=Eur Heart J：对比剂诱导急性肾损伤与PCI患者转归不佳相关, objectType=article, longId=31815, objectId=a64e31815c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a64e31815c5, replyNumber=0, likeNumber=78, createdTime=2014-04-19, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a64e31815c5, moduleTitle=Eur Heart J：对比剂诱导急性肾损伤与PCI患者转归不佳相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a64e31815c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786798, encodeId=19351e8679894, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=Am J Cardiol：共病和复发性冠脉疾病增多对PCI患者预后无显著影响？, objectType=article, longId=27547, objectId=2e3b2e54725, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e3b2e54725, replyNumber=0, likeNumber=86, createdTime=2014-09-06, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e3b2e54725, moduleTitle=Am J Cardiol：共病和复发性冠脉疾病增多对PCI患者预后无显著影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e3b2e54725)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786799, encodeId=eae71e8679978, content=<a href='/topic/show?id=f762138395a' target=_blank style='color:#2F92EE;'>#PCI患者#</a>, objectTitle=FDA多数专家反对坎格雷洛用于减少PCI患者血栓性心血管事件, objectType=article, longId=30598, objectId=174830598cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=174830598cc, replyNumber=0, likeNumber=60, createdTime=2014-06-11, rootId=0, userName=zhmscau, userId=2e94174, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=174830598cc, moduleTitle=FDA多数专家反对坎格雷洛用于减少PCI患者血栓性心血管事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=174830598cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PCI患者

2020-05-29

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

Lancet：支持使用血小板功能或基因检测来优化PCI患者的药物选择

2021-05-16

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

ESC 2020热点解读之房颤PCI患者抗凝治疗进展

2020-09-22

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

JAHA：肝脏纤维化评分作为预测择期PCI患者心血管预后的新工具

2021-12-11

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

JACC：单用替卡格雷对伴有糖尿病PCI患者的影响

2020-10-26

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

NEJM：高出血风险PCI患者的选择——无聚合物药物涂层支架vs聚合物药物洗脱支架

2020-10-31

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

TCT 2019 | TWILIGHT研究重磅发布，高危PCI患者使用替格瑞洛单药治疗获益显著

2020-01-11

仁心济世 (审核中...)

前往app查看评论内容

#PCI患者#

NEJM：原发性PCI患者口服P2Y12抑制剂的基因导向策略

2019-11-20

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

Lancet：替格瑞洛对糖尿病伴稳定冠状动脉疾病并且既往PCI患者有益

2020-05-24

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

JAMA：P2Y12抑制剂单药治疗对PCI患者心血管事件的影响研究

2020-03-29

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

Lancet：双抗血小板治疗缩短至6个月导致PCI患者心肌梗死风险增加

2018-10-21

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

Circulation：氯吡格雷低反应性PCI患者强化抗血小板治疗能获益更多？

2019-05-17

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

美国大学发现他汀能减少PCI患者不良心脏事件的发生

2019-02-04

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

JAHA：我国≥75岁PCI患者负荷双联抗血小板治疗无临床获益且出血风险增加

2018-04-29

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

Circ Cardiovasc Interv：他汀或可保护PCI患者手术中肾脏安全

2018-03-25

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

EHJ：中国择期PCI患者他汀强化未进一步获益(ISCAP研究)

2016-06-10

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

ESC 2015：PCI患者经桡动脉途径优于经股动脉（ISACS-TC注册研究）

2015-12-10

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

JACC：双降脂策略治疗PCI患者疗效更优

2015-09-26

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

Eur Heart J：对比剂诱导急性肾损伤与PCI患者转归不佳相关

2014-04-19

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

Am J Cardiol：共病和复发性冠脉疾病增多对PCI患者预后无显著影响？

2014-09-06

zhmscau (审核中...)

前往app查看评论内容

#PCI患者#

FDA多数专家反对坎格雷洛用于减少PCI患者血栓性心血管事件

2014-06-11

科室
- - 订阅+
  - 更多科室
工具
服务